Replimune Group, Inc.
HealthcareNASDAQ:REPL · NASDAQ Global Select
+$0.26 today
Vol 1.96M · Avg 7.45M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-9.20%
Period High
$12.63
Period Low
$1.70
Latest
$8.88
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Iovance Biotherapeutics, Inc.
NASDAQ:IOVA
$1.46B
Vir Biotechnology, Inc.
NASDAQ:VIR
$1.45B
ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP
$1.42B
MBX Biosciences, Inc. Common Stock
NASDAQ:MBX
$1.19B
MeiraGTx Holdings plc
NASDAQ:MGTX
$888.13M
Astria Therapeutics, Inc.
ATXS
$718.13M
Ginkgo Bioworks Holdings, Inc.
NYSE:DNA
$515.41M
Valneva SE
NASDAQ:VALN
$507.78M
Prime Medicine, Inc.
NASDAQ:PRME
$501.21M
Arvinas, Inc.
NASDAQ:ARVN
$489.07M
What is the latest REPL filing?
The latest filing shown is 4 dated Jun 3, 2026.
How many recent filings does REPL have?
Intrinsic Alpha currently shows 20 recent filings for REPL.
Explore More
Continue the stock analysis
Jump to another research area for this company.